Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-12-23FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride (generic) manufactured by Mylan Pharmaceuticals Inc.; this represen…
-
FDA approval · 2016-12-16FDA Approved: CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic chlordiazepoxide and amitriptyline hydrochloride combination from Mylan Pharmaceutic…
-
FDA approval · 2016-11-25FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for a venlafaxine hydrochloride generic product from BluePoint Laboratories under ANDA077653. Th…
-
FDA approval · 2016-11-01FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s original application for quetiapine fumarate, granting marketing authorization for a generic versi…
-
FDA approval · 2016-10-21FDA Approved: FLUOXETINE — Original Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's original application for fluoxetine, authorizing the marketing of a generic fluoxetine pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-10-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for aripiprazole from Torrent Pharmaceuticals Limited, enabling a generic version of the drug.
-
FDA approval · 2016-10-17FDA Approved: TRINTELLIX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Trintellix (vortioxetine) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2016-10-17FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Mirtazapine (Remeron) generic product filed by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2016-10-07FDA Approved: ARIPIPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Macleods Pharmaceuticals Limited's generic aripiprazole (ANDA 204111) based on its original application.
-
FDA approval · 2016-09-29FDA Approved: ARIPIPRAZOLE — Original Application (Dr.Reddys Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' generic aripiprazole under an original ANDA application. This action provides a generic option for th…
-
FDA approval · 2016-09-23FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for Rexulti (brexpiprazole) from Otsuka America Pharmaceutical, Inc., under NDA 205422.
-
FDA approval · 2016-09-12FDA Approved: ARIPIPRAZOLE — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved the original ANDA for a generic aripiprazole from Quallent Pharmaceuticals Health LLC. The approval covers a generic versio…
-
FDA approval · 2016-08-30FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Wellbutrin XL (bupropion hydrochloride) submitted by Bausch Health US LLC.
-
FDA approval · 2016-08-26FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PRISTIQ Extended-Release (desvenlafaxine succinate) by Wyeth/Pfizer, resulting in labeling chang…
-
FDA approval · 2016-08-26FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Exelan Pharmaceuticals' Bupropion Hydrochloride (XL) under an Original Application (ANDA 206556) as a generic extended-release …
-
FDA approval · 2016-08-19FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Endo USA, Inc.)
FDA approves Endo USA, Inc.'s fluoxetine hydrochloride as an Original Application, providing a generic version of fluoxetine hydrochloride.
-
FDA approval · 2016-08-19FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original application for a generic version of bupropion hydrochloride. This expands access to the antidepressant and smoking…
-
FDA approval · 2016-08-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for aripiprazole from Apotex Corp., authorizing a generic version of the drug. This action represent…
-
FDA approval · 2016-08-17FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved a generic sustained-release formulation of bupropion hydrochloride from ScieGen Pharmaceuticals (original application).
-
FDA approval · 2016-08-03FDA Approved: DULOXETINE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for a generic duloxetine product. Duloxetine is used to treat multiple conditi…
-
FDA approval · 2016-08-01FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approves a supplemental application for PROZAC (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2016-07-29FDA Approved: DESVENLAFAXINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's original application for generic desvenlafaxine for the treatment of major depressive disorder.
-
FDA approval · 2016-07-15FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a Supplemental Application for bupropion hydrochloride (Epic Pharma LLC), signaling regulatory approval for this generic produc…
-
FDA approval · 2016-07-15FDA Approved: DESVENLAFAXINE SUCCINATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for desvenlafaxine succinate (generic) under an ANDA.
-
FDA approval · 2016-06-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
FDA approved a supplemental application for venlafaxine hydrochloride (Vertical Pharmaceuticals, LLC). This action expands the sponsor's NDA…